Pharmaceutical discount agreement for Omalizumab via Open-House model
Status
Active
Submission Deadline
392 days remaining
Contracting authority
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen108 more open tenders view
Location
Erfurt, Germany
Procedure
Open Procedure · Supplies
Category
Pharmaceutical products.
Published
Reference
ted-473851-2026
Source
Conclusion of a non-exclusive pharmaceutical discount agreement for the active substance Omalizumab (ATC code R03DX05) according to § 130a para. 8 SGB V via an Open-House model.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 473851-2026HTML
- TED PDF — 473851-2026PDF
- TED XML — 473851-2026XML
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Additional details
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
Not allowed
Legal Basis
32014L0024